Grant: Catalyst Grant: Bioinformatics Approaches to Cancer Research
University of Toronto
$79,650.00
Functional variation in ultra-high-throughput sequence data
EF 2008-09
Résumé
Pancreatic cancer patients have very low survival rates and respond very poorly to all known treatments except surgery. New DNA sequencing technologies have made sequencing genomes of individual cancer patients feasible. This should allow us to identify all of the genetic differences between the tumor and the normal tissue, and between cancer patients and healthy individuals. Identifying these genetic differences will tell us why some people are genetically predisposed to pancreatic cancer, and what mutations occur as the cancer develops.
In practice, there are many technical challenges that need to be solved before the information in a tumor genome can actually be used for medical benefit. In this study we're proposing to work on several of the technical challenges that are raised by the new sequencing technology.
For example, we will use computer algorithms to search through billions of A, C, G and Ts to find the ones that are different between healthy people and those that have pancreatic cancer. Once we find them, we aim to determine which differences are important for disease and which are not. Although there are thousands of genetic differences between any two individuals, most of them are of no medical importance. We propose to look for the genetic differences that are likely to be important for pancreatic cancer, by considering where they fall in the genome. If genetic differences occur in regions of the genome that have been conserved over evolution, or affect important genes already thought to be important for pancreatic cancer, we predict that those more likely to predispose people to the disease.
Programme
Catalyst Grant: Bioinformatics Approaches to Cancer Research
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
182265
Name
Moses Alan M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Catalyst Grant: Bioinformatics Approaches to Cancer Research
Projecttitle
Functional variation in ultra-high-throughput sequence data
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$79,650
Cihrequipment2
$0
Programname2
Catalyst Grant: Bioinformatics Approaches to Cancer Research
Keyworddelim
Bioinformatics; Cancer; Computational Biology; Systems Biology
Abstract
Pancreatic cancer patients have very low survival rates and respond very poorly to all known treatments except surgery. New DNA sequencing technologies have made sequencing genomes of individual cancer patients feasible. This should allow us to identify all of the genetic differences between the tumor and the normal tissue, and between cancer patients and healthy individuals. Identifying these genetic differences will tell us why some people are genetically predisposed to pancreatic cancer, and what mutations occur as the cancer develops.
In practice, there are many technical challenges that need to be solved before the information in a tumor genome can actually be used for medical benefit. In this study we're proposing to work on several of the technical challenges that are raised by the new sequencing technology.
For example, we will use computer algorithms to search through billions of A, C, G and Ts to find the ones that are different between healthy people and those that have pancreatic cancer. Once we find them, we aim to determine which differences are important for disease and which are not. Although there are thousands of genetic differences between any two individuals, most of them are of no medical importance. We propose to look for the genetic differences that are likely to be important for pancreatic cancer, by considering where they fall in the genome. If genetic differences occur in regions of the genome that have been conserved over evolution, or affect important genes already thought to be important for pancreatic cancer, we predict that those more likely to predispose people to the disease.
Competitiondate
200903
Approvedterm2
1 yr 0 mth
Pinamesdelim
Moses, Alan M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $79,650~ $0~